A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.
177Lu-PNT6555 by POINT Biopharma Global for Metastatic Colorectal Cancer: Likelihood of Approval
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug